openPR Logo
Press release

Radiotheranostics Market Size, Application, Material, Region And Growth Forecast To 2033

Radiotheranostics Market Size

Radiotheranostics Market Size

The new report published by The Business Research Company, titled Radiotheranostics Global Market Report 2024 - Market Size, Trends, And Global Forecast 2024-2033, delivers an in-depth analysis of the leading size and forecasts, investment opportunities, winning strategies, market drivers and trends, competitive landscape, and evolving market trends.

As per the report, the radiotheranostics market size has grown rapidly in recent years. It will grow from $7.57 billion in 2023 to $8.74 billion in 2024 at a compound annual growth rate (CAGR) of 15.3%. The radiotheranostics market size is expected to see rapid growth in the next few years. It will grow to $14.61 billion in 2028 at a compound annual growth rate (CAGR) of 13.7%.

Download Free Sample Report @ https://www.thebusinessresearchcompany.com/sample.aspx?id=12270&type=smp

Rising Prevalence Of Cancer To Drive Market Growth
The increasing prevalence of cancer is expected to propel the growth of the radiotheranostics market going forward. Cancer is a condition in which some cells in the body develop uncontrollably and spread to other regions of the body. Radiotheranostics medicines are commonly employed in cancer to offer the ultimate notion of customized medicine by using paired diagnostic and therapeutic radionuclide probes for the selective and targeted detection and treatment of specific (typically cancer) cells, each of which is suited to the patient's underlying condition to enhance treatment efficiency and better clinical output. For instance, according to Cancer Research UK, a UK-based cancer research organization, approximately 18 million new cancer cases were detected in 2020. Further, there would be 28 million new cancer cases globally each year by 2040, a 54.9% increase over 2020, and is predicted to be more prominent in males (60.6% increase) than girls (48.8% increase). Therefore, the increasing prevalence of cancer drives the radiotheranostics market.

Product Innovations Transforming The Radiotheranostics Market
Product innovations are a key trend gaining popularity in the radiotheranostics market. Significant companies are concentrating their efforts on creating innovative products to strengthen their position in the market. For instance, in May 2023, Advanced Cyclotron Systems Inc., a Canada-based company that supplies and services cyclotrons predominantly used for producing medical isotopes, introduced TR-ALPHA for producing alpha-emitting radioisotopes to treat cancer. It is an appropriate solution to the market demand for a low-cost cyclotron capable of producing vast amounts of Astatine-211, one of the most promising alpha-emitting radioisotopes. The TR-ALPHA is also far smaller, less costly, and simpler to run than previous cyclotron models capable of manufacturing alpha-emitting radioisotopes. It is the ideal solution for hospitals, researchers, and institutions interested in running a dedicated cyclotron to efficiently produce enormous amounts of therapeutic alpha-emitting radioisotopes.

The radiotheranostics market covered in this report is segmented -

1) By Radioisotope: Technetium-99, Gallium-68, Iodine-131, Iodine-123, Fludeoxyglucose-18F, Yttrium-90, Lutetium (Lu) 177, Copper (Cu) 67, Copper (Cu) 64, Other Radioisotopes
2) By Approach: Targeted Therapeutic, Targeted Diagnostic
3) By Application: Oncology, Non-Oncology
4) By End-Users: Hospitals and Clinics, Pharmaceutical and Biotechnology Companies, Other End-Users

Buy Now & Get Exclusive Discount on this Report, Checkout link @
https://www.thebusinessresearchcompany.com/Discount?id=12270&type=discount

Major companies operating in the radiotheranostics market report are Lantheus Holdings Inc., Cardinal Health Inc., GE Healthcare Inc., Bayer AG, Novartis AG, Siemens Healthineers, Boston Scientific Corporation, Terumo Corporation, Orano Med, Curium SAS, IBA Molecular, The Eckert & Ziegler Group, Advanced Accelerator Applications (AAA), Telix Pharmaceuticals Limited., Abdera Therapeutics, Blue Earth Diagnostics, Sirtex Medical Limited, Y-mAbs Therapeutics Inc., ITM Radiopharma, NorthStar Medical Radioisotopes LLC, Trasis S.A., Molecular Targeting Technologies Inc., RadioMedix Inc, Clarity Pharmaceuticals, Actinium Pharmaceuticals Inc., Navidea Biopharmaceuticals Inc.

Contents of the report:
1. Executive Summary
2. Radiotheranostics Market Report Structure
3. Radiotheranostics Market Trends And Strategies
4. Radiotheranostics Market - Macro Economic Scenario
5. Radiotheranostics Market Size And Growth
…..
27. Radiotheranostics Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Explore the report store to make a direct purchase of the report @ https://www.thebusinessresearchcompany.com/report/radiotheranostics-global-market-report

Contact us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Latest Trending Press Releases: https://www.thebusinessresearchcompany.com/press-release.aspx

Learn More About The Business Research Company

The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Radiotheranostics Market Size, Application, Material, Region And Growth Forecast To 2033 here

News-ID: 3591862 • Views:

More Releases from The Business research company

Automotive Solid State Drive Market Report 2025-2034: Industry Overview, Trends, And Forecast Analysis
Automotive Solid State Drive Market Report 2025-2034: Industry Overview, Trends, …
"The Automotive Solid State Drive Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Current Automotive Solid State Drive Market Size and Its Estimated Growth Rate? The size of the automotive solid-state drive market has experienced substantial growth in the recent past. The market,
Evolving Market Trends In The Industrial Wastewater Treatment Industry: Technological Trends In Industrial Wastewater Treatment Market
Evolving Market Trends In The Industrial Wastewater Treatment Industry: Technolo …
The Industrial Wastewater Treatment Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Expected Industrial Wastewater Treatment Market Size During the Forecast Period? The Industrial Wastewater Treatment Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025
Rapid Surge In Dairy Product Consumption Fuels Expansion Of Milk Replacer Market: A Key Driver Powering Milk Replacers Market Growth In 2025
Rapid Surge In Dairy Product Consumption Fuels Expansion Of Milk Replacer Market …
The Milk Replacers Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Current Milk Replacers Market Size and Its Estimated Growth Rate? The Milk Replacers Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034.
Increasing Demand For Dairy Products Fuels Growth In The Milk-Fat Fractions Market: An Emerging Driver Transforming The Milk Fat Fractions Market Landscape
Increasing Demand For Dairy Products Fuels Growth In The Milk-Fat Fractions Mark …
The Milk Fat Fractions Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Projected Growth of the Milk Fat Fractions Market? The Milk Fat Fractions Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034.

All 5 Releases


More Releases for Radiotheranostics

Rise in Prevalence of Cancer will Drive Radiopharmaceutical Theranostics Market
Radiopharmaceutical Theranostics Market: Introduction According to the report, the global radiopharmaceutical theranostics market was valued at US$ 0.84 Bn in 2020 and is projected to expand at a CAGR of 11% from 2021 to 2031. Nuclear medicine imaging is primarily based on the principle of using radioactive isotopes attached to specific molecules (i.e., radiopharmaceutical agents or radiotracers) to examine key biologic processes, including disease pathophysiology. Radiopharmaceuticals are agents used for both diagnostic and therapeutic purposes. Organizations across the world classify these differently.
Nancyclotep has obtained €7 million in funding and has partnered with PMB to s …
Nancyclotep has embarked in a significant investment program to become a reference center for vectorized internal radiation therapy in France. In order to further establish its position, Nancyclotep has partnered with PMB, a subsidiary of the ALCEN group, which manufactures small cyclotrons and automated robotic systems for producing radiopharmaceuticals. Together, the two entities obtained a European funding of €7.2 million. This global project, totaling more than €15 M, will allow the
Nancyclotep is positioning itself to become the reference center for Vectorized …
Nancyclotep, a provider of solutions for the transfer of radiopharmaceuticals to the clinical setting, has announced its intention to become the reference center for Vectorized Internal Radiotherapy for the Greater East region, in collaboration with the University Hospital of Nancy and the support of the Regional Health Agency. A substantive investment will allow a significant increase in the number of shielded-rooms for patients in the short term, in conjunction with
02-01-2018 | Health & Medicine
1962
Most promising radiopharmaceuticals on the market by 2024-2026
MEDraysintell releases a new report covering the most promising radiopharmaceuticals (radiodiagnostics, radiotherapeutics and radiotheranostics) currently in clinical stage development which have the highest chances to reach the market by 2024-2026. This new report covers 35 products along with the profile of the 27 companies developing these products, and aims to advice on the potential for investments, merger and acquisitions (M&A), technology and market development existing in this healthcare technology. Detailed table of
Impulse from radiotherapeutics confirms accelerated growth of nuclear medicine
MEDraysintell releases its new Nuclear Medicine World Market Report and Directory–Edition 2017, a 1,100-page document that provides an exhaustive description and analysis of more than 390 products, including over 140 radiopharmaceuticals under clinical development, with a comprehensive profile of 193 companies and institutions active in the radiopharmaceuticals industry. Detailed table of contents and sample pages available upon request a peg@medraysintell.com MEDraysintell estimates that the global market for nuclear medicine reached US$ 4.5